Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 8, Pages 3022
Publisher
MDPI AG
Online
2020-04-24
DOI
10.3390/ijms21083022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases
- (2020) Souvik Das et al. Frontiers in Oncology
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Michael Gnant et al. LANCET ONCOLOGY
- Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2019) Kathy Pan et al. JOURNAL OF CLINICAL ONCOLOGY
- From latency to overt bone metastasis in breast cancer: Potential for treatment and prevention
- (2019) Fernando Salvador et al. JOURNAL OF PATHOLOGY
- Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
- (2019) Francesco Perrone et al. EUROPEAN JOURNAL OF CANCER
- FOXF2 reprograms breast cancer cells into bone metastasis seeds
- (2019) Shuo Wang et al. Nature Communications
- Clinical benefits of bone targeted agents in early breast cancer
- (2019) Robert Coleman BREAST
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
- (2019) Robert Coleman et al. LANCET ONCOLOGY
- Cancer Treatment and Bone Health
- (2018) Catherine Handforth et al. CALCIFIED TISSUE INTERNATIONAL
- Comparative study of neoadjuvant chemotherapy with and without Zometa® for management of locally advanced breast cancer with serum VEGF as primary endpoint: the NEOZOL study
- (2018) Loïc Lelièvre et al. Clinical Breast Cancer
- Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
- (2018) Stephanie Strobl et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Zoledronate suppresses VEGF‑induced capillary tube formation and inhibits expression of interferon‑induced transmembrane protein‑1 in human umbilical vein endothelial cells
- (2018) Beom�Su Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
- (2018) Janet Brown et al. JNCI-Journal of the National Cancer Institute
- Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
- (2018) Janet Brown et al. JNCI-Journal of the National Cancer Institute
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
- (2018) Jules A. Westbrook et al. JOURNAL OF PATHOLOGY
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- The value of biomarkers in bone metastasis
- (2017) Stella D'Oronzo et al. EUROPEAN JOURNAL OF CANCER CARE
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Sukhbinder Dhesy-Thind et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial
- (2017) Robert Coleman et al. LANCET ONCOLOGY
- The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
- (2017) Mekonnen Sisay et al. OncoTargets and Therapy
- Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro
- (2017) Mauro Cives et al. Oncotarget
- Characteristics and Significance of the Pre-metastatic Niche
- (2016) Yang Liu et al. CANCER CELL
- Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
- (2016) J.R. Kroep et al. EUROPEAN JOURNAL OF CANCER
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
- (2016) Emma Nolan et al. NATURE MEDICINE
- Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents
- (2016) Ryota Tanaka et al. ONCOLOGIST
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
- (2015) P. Hadji et al. ANNALS OF ONCOLOGY
- Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
- (2015) S. D’Oronzo et al. CANCER TREATMENT REVIEWS
- Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
- (2015) Milica Pavlovic et al. JNCI-Journal of the National Cancer Institute
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
- (2015) Alison T. Stopeck et al. SUPPORTIVE CARE IN CANCER
- Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
- (2015) Milica Pavlovic et al. JNCI-Journal of the National Cancer Institute
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
- (2014) A. Charehbili et al. ANNALS OF ONCOLOGY
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
- (2014) Robert Coleman et al. LANCET ONCOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Real-Time Intravital Imaging Establishes Tumor-Associated Macrophages as the Extraskeletal Target of Bisphosphonate Action in Cancer
- (2014) Simon Junankar et al. Cancer Discovery
- Effects of RANKL-Targeted Therapy in Immunity and Cancer
- (2014) Michael L. Cheng et al. Frontiers in Oncology
- Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
- (2013) Shirin Kalyan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
- (2012) P.G. Dedes et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
- (2012) R L Aft et al. BRITISH JOURNAL OF CANCER
- The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
- (2012) Fanyan Meng et al. CANCER AND METASTASIS REVIEWS
- CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
- (2012) J.-H. Lee et al. CANCER RESEARCH
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients
- (2010) Florian Cabillic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
- (2010) A. J. Roelofs et al. CURRENT PHARMACEUTICAL DESIGN
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
- (2010) Michio Naoe et al. ONCOLOGY RESEARCH
- Do RANKL inhibitors (denosumab) affect inflammation and immunity?
- (2010) S. Ferrari-Lacraz et al. OSTEOPOROSIS INTERNATIONAL
- Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor
- (2009) Zuzana Saidak et al. EXPERIMENTAL CELL RESEARCH
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started